| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 2804 |
| 1 | OLANZAPINE | 2756 |
| 2 | RISPERIDONE | 2265 |
| 3 | ARIPIPRAZOLE | 1723 |
| 4 | HALOPERIDOL LACTATE | 1677 |
| 5 | HALOPERIDOL | 1646 |
| 6 | CLOZAPINE | 1335 |
| 7 | LORAZEPAM | 1322 |
| 8 | ARIPIPRAZOLE ORAL | 952 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 952 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE | 370 | 0.1027 |
| 1 | FLUPHENAZINE DECANOATE | 42 | 0.0966 |
| 2 | DANTROLENE SODIUM | 79 | 0.0690 |
| 3 | HALOPERIDOL LACTATE | 1677 | 0.0672 |
| 4 | PIMOZIDE | 29 | 0.0602 |
| 5 | HALOPERIDOL DECANOATE | 96 | 0.0551 |
| 6 | CHLORPROMAZINE | 262 | 0.0417 |
| 7 | LOXAPINE | 159 | 0.0398 |
| 8 | OLANZAPINE | 2756 | 0.0394 |
| 9 | CHLORPROMAZINE HYDROCHLORIDE | 37 | 0.0388 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 7646 |
| 1 | Benzodiazepine [EPC] | 2906 |
| 2 | Typical Antipsychotic [EPC] | 1668 |
| 3 | Mood Stabilizer [EPC] | 1157 |
| 4 | Anti-epileptic Agent [EPC] | 1133 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 609 |
| 6 | Proton Pump Inhibitor [EPC] | 426 |
| 7 | Opioid Agonist [EPC] | 292 |
| 8 | Aromatic Amino Acid [EPC] | 255 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 247 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 1668 | 0.0666 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 247 | 0.0317 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 31 | 0.0250 |
| 3 | Tricyclic Antidepressant [EPC] | 9 | 0.0188 |
| 4 | Atypical Antipsychotic [EPC] | 7646 | 0.0170 |
| 5 | Aldehyde Dehydrogenase Inhibitor [EPC] | 14 | 0.0123 |
| 6 | Catechol-O-Methyltransferase Inhibitor [EPC] | 62 | 0.0123 |
| 7 | Influenza A M2 Protein Inhibitor [EPC] | 138 | 0.0088 |
| 8 | Benzodiazepine Antagonist [EPC] | 7 | 0.0079 |
| 9 | Monoamine Oxidase Inhibitor [EPC] | 22 | 0.0071 |